Exosomes/microvesicles as a mechanism of cell-to-cell communication

Slides:



Advertisements
Similar presentations
Volume 131, Issue 1, Pages (July 2006)
Advertisements

Volume 81, Issue 11, Pages (June 2012)
Volume 72, Issue 2, Pages (July 2007)
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Volume 70, Issue 1, Pages (July 2006)
Stem cells in the embryonic kidney
Volume 79, Issue 11, Pages (June 2011)
Volume 73, Issue 11, Pages (June 2008)
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice  Ryotaro Hashizume, MD, Aika Yamawaki-Ogata,
Volume 130, Issue 2, Pages (February 2006)
1Giuseppe P. Segoloni, 1Giovanni Camussi
Glycoprotein Nonmelanoma Clone B Regulates the Crosstalk between Macrophages and Mesenchymal Stem Cells toward Wound Repair  Bing Yu, Talib Alboslemy,
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 67, Issue 5, Pages (May 2005)
Adenosine-induced apoptosis in glomerular mesangial cells
Volume 68, Issue 6, Pages (December 2005)
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
Volume 80, Issue 8, Pages (October 2011)
Volume 74, Issue 7, Pages (October 2008)
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 69, Issue 8, Pages (April 2006)
Smad7 gene transfer inhibits peritoneal fibrosis
Paola Romagnani, Benjamin D. Humphreys  Kidney International 
Volume 82, Issue 8, Pages (October 2012)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 82, Issue 10, Pages (November 2012)
Volume 78, Issue 1, Pages (July 2010)
Exosomes in liver pathology
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 115, Issue 1, Pages (July 1998)
Detection of bone marrow–derived lung epithelial cells
Volume 134, Issue 3, Pages (March 2008)
Katerina Akassoglou, Wei-Ming Yu, Pinar Akpinar, Sidney Strickland 
Volume 74, Issue 5, Pages (September 2008)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Rafael Gongora, Robert P Stephan, Zhixin Zhang, Max D Cooper  Immunity 
M. Svensson, H. Irjala, C. Svanborg, G. Godaly  Kidney International 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Stem cell plasticity revisited: The continuum marrow model and phenotypic changes mediated by microvesicles  Peter J. Quesenberry, Mark S. Dooner, Jason.
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Volume 70, Issue 1, Pages (July 2006)
Gene transfer of truncated IκBα prevents tubulointerstitial injury
Volume 72, Issue 4, Pages (August 2007)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 80, Issue 5, Pages (September 2011)
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 56, Issue 4, Pages (October 1999)
Volume 75, Issue 10, Pages (May 2009)
Volume 77, Issue 4, Pages (February 2010)
Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors  Maria L. Angelotti, Elena Lazzeri, Laura.
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 34, Issue 4, Pages (April 2011)
Volume 8, Issue 3, Pages (January 1998)
Volume 85, Issue 1, Pages (January 2014)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Volume 129, Issue 2, Pages (April 2007)
Kunio Matsumoto, Toshikazu Nakamura  Kidney International 
New drug toxicities in the onco-nephrology world
Gillian Coakley, Rick M. Maizels, Amy H. Buck  Trends in Parasitology 
Exosomes in urine: Who would have thought…?
Markus Bitzer, Iddo Z. Ben-Dov, Thomas Thum  Kidney International 
Volume 19, Issue 6, Pages (June 2011)
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis 
Cultured human glomerular mesangial cells express the C5a receptor
Volume 8, Issue 6, Pages (June 2017)
Volume 19, Issue 2, Pages (February 2011)
Periodic Activation of Wnt/β-Catenin Signaling Enhances Somatic Cell Reprogramming Mediated by Cell Fusion  Frederic Lluis, Elisa Pedone, Stefano Pepe,
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Presentation transcript:

Exosomes/microvesicles as a mechanism of cell-to-cell communication Giovanni Camussi, Maria C. Deregibus, Stefania Bruno, Vincenzo Cantaluppi, Luigi Biancone  Kidney International  Volume 78, Issue 9, Pages 838-848 (November 2010) DOI: 10.1038/ki.2010.278 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Schematic representation of exosome and shedding vesicle formation. (a) Release of exosomes. Exosomes are accumulated within the multivesicular bodies as a result of endosome compartmentalization. The vesicles present in multivesicular bodies may undergo degradation or exocytosis. The exocytic multivesicular bodies fuse with membrane after cell stimulation and release exosomes. (Upper inset) Representative transmission electron microscopy showing exocytosis of exosomes from the surface of a mesenchymal stem cell (original magnification × 15,000). (Lower inset) Representative transmission electron microscopy showing a multivesicular body within a mesenchymal stem cell (original magnification × 10,000). (b) Production of shedding vesicles from the cell surface. Shedding vesicles are sorted out from cytoplasm by budding of cell plasmamembrane in response to cell stimulation. (Left micrograph) Transmission electron microscopy panel showing vesicles shed from the surface of an endothelial progenitor cell (original magnification × 10,000); the inset shows the high magnification ultrastructure of a vesicle shed from an endothelial progenitor (original magnification × 25,000). (Right micrograph) Transmission electron microscopy panel showing an aspect of cell membrane budding in an endothelial progenitor cell during microvesicle (MV) formation (original magnification × 15,000). The mechanisms involved in MV cargo as well as those involved in membrane-sorting processes remain at present largely unknown. Kidney International 2010 78, 838-848DOI: (10.1038/ki.2010.278) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Schematic representation of mechanisms involved in microvesicle (MV)-mediated cell-to-cell communication. (a) MVs may act as a ‘signaling complex’ through surface-expressed ligands that directly stimulate the target cells. (b) MVs may transfer receptors between cells. (c) MVs may deliver functional proteins or infectious particles to target cells. (d) MVs may transfer genetic information via mRNA, microRNA (miRNA), or transcription factors from one cell to another. Kidney International 2010 78, 838-848DOI: (10.1038/ki.2010.278) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Schematic representation of bidirectional exchange of genetic information between stem cells and tissue-injured cells mediated by microvesicles (MVs). (a) MVs released from tissue-injured cells may reprogram the phenotype of stem cells to acquire tissue-specific features by delivering to stem cells the mRNAs and/or microRNAs (miRNAs) of tissue cells. (b) MVs produced by stem cells recruited from the circulation or from resident stem cells may reprogram tissue-injured cells by delivering mRNA and/or miRNA that induce the de-differentiation, the production of soluble paracrine mediators, and the cell cycle re-entry of these cells favoring tissue regeneration. BM, bone marrow; EGF, epiotermal growth factor; HGF, hepatocyte growth factor; IGF-1, insulin-like growth factor-1; MSP, macrophage stimulating protein; VEGF, vascular endothelial growth factor. Kidney International 2010 78, 838-848DOI: (10.1038/ki.2010.278) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Effect of mesenchymal stem cell (MSC)-derived microvesicles (MVs) in vitro on cultured mouse tubular epithelial cells (TECs) and in vivo on glycerol-induced acute kidney injury (AKI) in severe combined immunodeficient (SCID) mice (see Bruno et al.47). (a) Representative confocal micrograph showing the internalization by mouse TECs (30 min at 37 °C) of 30 μg/ml MVs labeled with PKH26 (red). Nuclei were stained by Hoechst dye (blue; original magnification × 400). The mRNA horizontal transfer and human protein translation by mouse TECs treated with human MSC-derived MVs was shown by reverse transcriptase-PCR (RT-PCR) for a specific human mRNA using small ubiquitin-like modifier-1 (SUMO-1) as target mRNA and by immunofluorescence using anti-human SUMO-1 antibodies. (b) A band of PCR products specific for human SUMO-1 of the expected size (90 bp) was detected in a 4% agarose gel electrophoresis in TECs cultured in the presence of 30 μg/ml MVs, whereas it was absent in TEC alone. As positive control, the extract of human bone marrow-derived MSC (BM-MSC) was used. (c, d) Representative micrographs showing the expression of human SUMO-1 proteins by mouse TECs cultured in the absence or in the presence of 30 μg/ml MVs for 24 h. SUMO-1 was detectable in the cytoplasm and nuclei of TECs incubated with MVs (d) but not in untreated TECs (c). Nuclei were counterstained with Hoechst dye (blue; original magnification × 400). (e–g) Representative micrographs of semifine sections (e, f) and transmission electron microscopy (g) showing the diffuse tubular injury characterized by blebbing, loss of brush border, and necrosis of TECs and by the presence of intraluminal tubular casts in mice 5 days after glycerol-induced AKI. (h–j) Representative micrographs of semifine sections (h, i) and transmission electron microscopy (j) showing the morphological recovery induced by treatment with 10 μg MSC-derived MVs in mice 5 days after glycerol-induced AKI. The inset in (h) shows the accumulation of PKH26-labeled MVs within the TECs (original magnification e and h × 150; f, g, and i × 600; and j × 3000). (k–n) The detection of human protein expression in kidneys of mice treated with human MSC-derived MVs indicated the translation of human proteins by the horizontally transferred mRNA into TECs in vivo. Representative confocal micrographs showing the presence of staining for human SUMO-1 protein with cytoplasmic and nuclear expression in kidney sections of AKI mice treated with MVs and killed 48 h later (k, l) or in control mice untreated with MVs (m, n). Nuclei were counterstained with Hoechst dye (original magnification × 400). Kidney International 2010 78, 838-848DOI: (10.1038/ki.2010.278) Copyright © 2010 International Society of Nephrology Terms and Conditions